Skip to main content
Toggle navigation
Login
Search
Home
iwCLL X / Twitter
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Tweet
Shweta Hakre, PhD
US Medical Affairs, AstraZeneca Pharmaceuticals, Gaithersburg, MD, USA
N/A
Poster(s):
2007 - Real-World Duration of Venetoclax Treatment for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
